Sputnik Light
AXP000171.1 · Vaccine
- Platform
- human adenovirus 26 (non-replicating)
- Targets
- SARS-CoV-2 S
- Originator
- Gamaleya Research Institute of Epidemiology and Microbiology
- Sponsor
- Gamaleya Research Institute of Epidemiology and Microbiology
Names
| Name | Type | Source |
|---|---|---|
| Sputnik Light | preferred name, brand | curator, wikidata |
| Gam-COVID-Vac component I ambiguous | synonym | wikidata |
Virus
- Role
- Vaccine vector
- Family
- Adenoviridae
- Virus
- human adenovirus 26
- Strain
- rAd26
- Replication
- non replicating
- Modifications
- single non-replicating rAd26 dose encoding the full-length SARS-CoV-2 spike
- Transgenes
- SARS-CoV-2 spike
- Route
- intramuscular
- Source
- evidence
Approvals
| Agency | Region | Date | Status | Brand | Indication | Source |
|---|---|---|---|---|---|---|
| other | RU | 2021-05-06 | conditional | Sputnik Light | Single-dose prevention of COVID-19 | source |
Clinical trials (2)
| Trial | Title | Status | Phase | Start | Primary completion | Enrolment | Conditions |
|---|---|---|---|---|---|---|---|
| NCT04741061 | Study to Evaluate Efficacy, Immunogenicity and Safety of the Sputnik-Light | Unknown | Phase 3 | 2021-02-19 | 2021-12-31 | 6000 | COVID-19 Prevention |
| NCT04713488 | An Open Study on the Safety, Tolerability, and Immunogenicity of "Sputnik Light" Vaccine | Unknown | Phase 1/2 | 2021-01-15 | 2021-07-20 | 110 | COVID-19 Prevention |
Recent changes
No changes recorded in its trials yet.
Clinical papers
No confirmed clinical papers yet.
Other papers
Preclinical studies, reviews and other papers that name it.
| PubMed | Title | Journal | Year | Linked by |
|---|---|---|---|---|
| PMID 40264579 | The Parameters of Long-Term Humoral Immunity Induced by a Single Injection of the Sputnik Light Vaccine Among Noninfected Volunteers and Those Infected with SARS-CoV-2. | Acta naturae | 2025 | name in title: Sputnik Light |
| PMID 38282667 | Assessing the prevalence and patterns of COVID-19 vaccine side effects among Syrian adults: A cross-sectional study. | Preventive medicine reports | 2024 | name in abstract: Sputnik Light |
| PMID 38413637 | Exploring the reported adverse effects of COVID-19 vaccines among vaccinated Arab populations: a multi-national survey study. | Scientific reports | 2024 | name in abstract: Sputnik Light |
| PMID 38543960 | Comparative Analysis of SARS-CoV-2 Antibody Responses across Global and Lesser-Studied Vaccines. | Vaccines | 2024 | name in abstract: Sputnik Light |
| PMID 39100722 | COVID-19 Vaccines Breakthrough Infections and Adverse Effects Reported by the Birzeit University Community in Palestine. | International journal of general medicine | 2024 | name in abstract: Sputnik Light |
| PMID 39772064 | Receptor Binding Domain-Specific B Cell Memory Responses Among Individuals Vaccinated Against SARS-CoV-2. | Vaccines | 2024 | name in abstract: Sputnik Light |
| PMID 37919737 | The impact of geo-political socio-economic factors on vaccine dissemination trends: a case-study on COVID-19 vaccination strategies. | BMC public health | 2023 | name in abstract: Sputnik Light |
| PMID 35101893 | Boosting of the SARS-CoV-2-Specific Immune Response after Vaccination with Single-Dose Sputnik Light Vaccine. | Journal of immunology (Baltimore, Md. : 1950) | 2022 | name in title: Sputnik Light |
| PMID 35751563 | Comparison of the immunogenicity of five COVID-19 vaccines in Sri Lanka. | Immunology | 2022 | name in abstract: Sputnik Light |
| PMID 35943061 | Immunity after COVID-19 vaccination in people with higher risk of compromised immune status: a scoping review. | The Cochrane database of systematic reviews | 2022 | name in abstract: Sputnik Light |
| PMID 36138385 | COVID-19 vaccines effectiveness against symptomatic SARS-CoV-2 during Delta variant surge: a preliminary assessment from a case-control study in St. Petersburg, Russia. | BMC public health | 2022 | name in abstract: Sputnik Light |
| PMID 36366311 | Sputnik Light and Sputnik V Vaccination Is Effective at Protecting Medical Personnel from COVID-19 during the Period of Delta Variant Dominance. | Vaccines | 2022 | name in title: Sputnik Light |
| PMID 34746910 | An open, non-randomised, phase 1/2 trial on the safety, tolerability, and immunogenicity of single-dose vaccine "Sputnik Light" for prevention of coronavirus infection in healthy adults. | The Lancet regional health. Europe | 2021 | name in title: Sputnik Light |
| PMID 35146337 | Review of COVID-19 viral vector-based vaccines and COVID-19 variants. | Le infezioni in medicina | 2021 | name in abstract: Sputnik Light |
Notes
The first (rAd26) component of Gam-COVID-Vac alone, authorised in Russia as a separate single-dose product on 6 May 2021. Kept apart from AXP000170 because it is registered and marketed as its own product, but it is the same construct as that regimen's first dose: a candidate for merging if the registry decides route/regimen variants should not be split.
How to cite
Sputnik Light (AXP000171.1). The Abstractinator program registry, release 2026-11-17+2c46e992acfc. https://abstractinator.me/registry/AXP000171.html
Something wrong or missing? Suggest a correction (a GitHub issue; please link your evidence). Entry created 2026-11-11, updated 2026-11-11.